Shanxi Shumisheng Pharmaceutical

Shanxi Shumisheng Pharmaceutical is a Chinese pharmaceutical company focused on the production and commercialization of chemical drug formulations, particularly for chronic conditions. The company's core business involves the manufacturing of oral solid dosage forms, including sustained-release tablets for metabolic and cardiovascular diseases. Key products in its portfolio include generic versions of Metformin and Gliclazide, which are essential for managing type 2 diabetes. Based in the Jinzhong development zone of Shanxi Province, the firm operates GMP-certified facilities to serve the regional and national Chinese markets. The company emphasizes quality control and modern manufacturing techniques to ensure the efficacy of its generic drug offerings.